Company Filing History:
Years Active: 2012
Title: Katherinie Macfarlane: Innovator in Pharmaceutical Chemistry
Introduction
Katherinie Macfarlane is a notable inventor based in Huntingdale, Australia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can be used in the treatment of viral infections.
Latest Patents
Katherinie holds a patent for "Bicyclic pyrimidinones and uses thereof." This invention provides a compound of Formula I or a pharmaceutically acceptable derivative, salt, or prodrug thereof. The patent outlines a method for the treatment or prophylaxis of a viral infection in a subject by administering an effective amount of the compound. Additionally, it includes a pharmaceutical composition or medicament comprising the compound.
Career Highlights
Katherinie is associated with Avexa Limited, a company focused on developing innovative therapies. His work has led to advancements in the pharmaceutical industry, particularly in antiviral treatments.
Collaborations
Katherinie has collaborated with notable colleagues, including Eric Dale Jones and Jonathan Alan Victor Coates. These partnerships have contributed to the success of his research and development efforts.
Conclusion
Katherinie Macfarlane's work in pharmaceutical chemistry exemplifies innovation in the treatment of viral infections. His contributions through patents and collaborations highlight the importance of research in advancing medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.